[S18★☆] Recent trends and future perspectives for non-clinical pharmacokinetics and safety evaluation of therapeutic monoclonal antibodies —at the dawn of a new era

2:45 PM - 3:10 PM JST(5:45 AM - 6:10 AM UTC)

[S18-5] The Current Status of Nonclinical Safety Evaluation of Antibody Therapeutics

○Mutsumi Suzuki^1,2 (1. Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA, 2. TR Labs, Kyowa Kirin)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.